Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom. Quotient, ...
Quotient Therapeutics emerged from stealth Nov. 21 with $50 million in funding from the life science investment firm Flagship Pioneering. Quotient’s platform hunts for new drug targets by using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results